Simtuzumab | m-entrepreneurship.com

Product Name :
Simtuzumab

Search keywords :
Simtuzumab

drugId :
null

Target Vo:
Lysyl oxidase homolog 2

Target Vo Short Name :
LOXL2

Moa_Name:
Lysyl oxidase homolog 2 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Gilead Sciences Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
HIV Infections

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Bak Rabbit mAb Protocol
Lokivetmab custom synthesis
BMP2 Antibody: BMP2 Antibody is an unconjugated, approximately 13/44 kDa, rabbit-derived, anti-BMP2 polyclonal antibody. BMP2 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, rat, and predicted: chicken, dog, cow, horse, rabbit, sheep background without labeling.

Author: Betaine hydrochloride

Related Posts